Mitochondrial metabolism sustains DNMT3A-R882-mutant clonal haematopoiesis
Malgorzata Gozdecka(Wellcome Sanger Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Konstantinos Tzelepis(Wellcome/MRC Cambridge Stem Cell Institute), Theodoros Georgomanolis(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Pedro M. Quirós(Universidad de Oviedo), Vijaya Baskar Mahalingam Shanmugiah(Wellcome/MRC Cambridge Stem Cell Institute), Christian Frezza(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), George Giotopoulos(Wellcome/MRC Cambridge Stem Cell Institute), Paolo Gallipoli(Wellcome/MRC Cambridge Stem Cell Institute), James A. Nathan(University of Cambridge), Ludovica Marando(Wellcome/MRC Cambridge Stem Cell Institute), Guinevere L. Grice(University of Cambridge), Rula Bany Bakar(MRC Epidemiology Unit), Brian J.P. Huntly(Wellcome/MRC Cambridge Stem Cell Institute), Richard J Stopforth(MRC Epidemiology Unit), Aristi Damaskou(Wellcome/MRC Cambridge Stem Cell Institute), Rachael Wilson(Wellcome/MRC Cambridge Stem Cell Institute), Clea Bárcena(Universidad de Oviedo), Justyna Rak(Wellcome/MRC Cambridge Stem Cell Institute), William G. Dunn(Wellcome/MRC Cambridge Stem Cell Institute), Ryan Asby(Wellcome/MRC Cambridge Stem Cell Institute), Penny Wright(Canterbury Health Laboratories), Arthur Kaser(University of Cambridge), Margarete A. Fabre(AstraZeneca (United Kingdom)), Eliza Yankova(Wellcome/MRC Cambridge Stem Cell Institute), Muxin Gu(Wellcome/MRC Cambridge Stem Cell Institute), Graham Duddy(The Francis Crick Institute), Annalisa Mupo(Wellcome Sanger Institute), Monika Dudek(Wellcome/MRC Cambridge Stem Cell Institute), Siddhartha Kar(University of Cambridge), Nisha Narayan(Wellcome/MRC Cambridge Stem Cell Institute), Paul Carter(University of Cambridge), Dean C. Pask(Wellcome/MRC Cambridge Stem Cell Institute), Sean Wen(Wellcome/MRC Cambridge Stem Cell Institute), Slavé Petrovski(AstraZeneca (United Kingdom)), Laura Bond(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Mitchell(AstraZeneca (Australia)), A. Ramesh(Wellcome/MRC Cambridge Stem Cell Institute), Jonathan Cooper(Wellcome Sanger Institute), Sarah J. Horton(Wellcome/MRC Cambridge Stem Cell Institute), Matthew McLoughlin(Wellcome/MRC Cambridge Stem Cell Institute), Kosuke Yusa(Kyoto University)
Cited by 34
Related Papers
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
|The Lancet|2005|3.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k